image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 2.12
-5.24 %
$ 4 M
Market Cap
-0.01
P/E
CASH FLOW STATEMENT
-12.6 M OPERATING CASH FLOW
-88.97%
-13 K INVESTING CASH FLOW
-0.22%
8.86 M FINANCING CASH FLOW
92.01%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis PainReform Ltd.
image
00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)(14m)(14m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -14.6 M
Depreciation & Amortization 16 K
Capital Expenditures -13 K
Stock-Based Compensation 310 K
Change in Working Capital 1.66 M
Others 1.56 M
Free Cash Flow -12.6 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (14.6) (9.3) (8.8) (7.2) (4.1) (1.3) (0.8) (1.1)
Depreciation & Amortization 16 K 15 K 15 K 7 K 1.0 1 K 0 0
Deferred Income Tax 0 0 0 0 (1.0) 2 K 0 0
Stock Based Compensation 0.3 0.8 1.4 0.8 38 K 89 K 0 18 K
Other Operating Activities 16 K 0.2 0.3 0.4 2.3 0.6 0.3 0.3
Change in Working Capital 1.7 1.6 0.7 (0.5) (0.9) 35 K (0.1) 23 K
Cash From Operations (12.6) (6.7) (6.5) (6.6) (2.6) (0.6) (0.6) (0.9)
INVESTING CASH FLOW
Capital Expenditures 13 K 9 K 6 K 50 K 10 K 0 0 0
Other Items 0 6.0 (6.0) 0 0 0 0 0
Cash From Investing Activities 13 K 6.0 (6.0) 50 K 10 K 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0.2 0.5 0.7
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 3.5 2.9 0 1.5 0 1.3 0 0
Cash From Financing Activities 8.9 4.6 0 7.5 17.3 1.5 0.5 0.7
CHANGE IN CASH
Net Change In Cash (3.8) 3.9 (12.5) 0.9 14.7 0.9 (0.1) (0.2)
FREE CASH FLOW
Free Cash Flow (12.6) (6.7) (6.5) (6.6) (2.6) (0.6) (0.6) (0.9)